Want to see NAKA full AI Analyst Report?
Top Page
Nakamoto Inc
(NASDAQ:NAKA)
Select Model
Select Model
Rating:50Neutral
Price Target:
$6.00
▲(23.20% Upside)
Action:Reiterated
Date:08/20/26
The score is held down primarily by very weak financial performance (severe losses and ongoing cash burn). Technicals are mixed—near-term momentum is positive but appears overextended and the longer-term trend is still negative—while valuation provides little support given losses and no dividend yield. Corporate actions (refinancing, compliance regained, and a buyback plan) modestly improve the outlook but do not outweigh the current fundamental risks.
Positive Factors
Exceptional Revenue Growth
The sharp revenue increase indicates significant business expansion and customer or market adoption. If the company can retain this scale while improving efficiency, the larger revenue base could support stronger operating leverage over the next several quarters.
Negative Factors
Severe Unprofitability
Extremely deep operating and net losses indicate that revenue growth is not translating into a viable earnings model. Persistent losses can consume equity, weaken access to capital, and make future growth dependent on additional financing or major cost restructuring.
Read all positive and negative factors
Positive Factors
Negative Factors
Exceptional Revenue Growth
The sharp revenue increase indicates significant business expansion and customer or market adoption. If the company can retain this scale while improving efficiency, the larger revenue base could support stronger operating leverage over the next several quarters.
Read all positive factors
Nakamoto Inc (NAKA) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$89.65M
Dividend YieldN/A
Average Volume (3M)30.98M
Price to Earnings (P/E)―
Beta (1Y)4.16
Revenue Growth1658.09%
EPS Growth-3.49%
CountryUS
Employees65
SectorGeneral
Sector StrengthN/A
IndustryFinancial - Capital Markets
Share Statistics
EPS (TTM)-35.85
Shares Outstanding17,894,943
10 Day Avg. Volume32,220,503
30 Day Avg. Volume30,978,537
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.31
Price to Sales (P/S)87.61
P/FCF Ratio-6.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$12.00Price Target Upside146.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-7.05
Revenue Forecast (FY)$55.96M
Nakamoto Inc Business Overview & Revenue Model
Company Description
Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. The company provides commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Na...
How the Company Makes Money
null...
Nakamoto Inc Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
16
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.38M | 1.82M | 2.72M | 3.77M | 3.79M | 2.50M |
| Gross Profit | 5.60M | -9.27M | -842.57K | 3.54M | 3.63M | 914.92K |
| EBITDA | -268.01M | -44.93M | -3.00M | -1.36M | -2.42M | 124.74K |
| Net Income | -420.55M | -52.23M | -3.62M | -1.62M | -2.54M | 149.34K |
Balance Sheet | ||||||
| Total Assets | 422.51M | 730.61M | 3.68M | 1.10M | 947.00K | 447.64K |
| Cash, Cash Equivalents and Short-Term Investments | 19.07M | 22.58M | 2.27M | 525.50K | 186.92K | 94.69K |
| Total Debt | 164.70M | 209.92M | 783.68K | 636.38K | 391.13K | 109.81K |
| Total Liabilities | 186.10M | 216.35M | 1.11M | 1.21M | 565.98K | 174.56K |
| Stockholders Equity | 236.41M | 514.26M | 2.57M | -108.41K | 381.01K | 273.09K |
Cash Flow | ||||||
| Free Cash Flow | -45.64M | -23.75M | -3.48M | -463.91K | -457.77K | 57.84K |
| Operating Cash Flow | -45.13M | -23.51M | -3.07M | -449.49K | -140.38K | 121.44K |
| Investing Cash Flow | -643.20M | -680.02M | -401.63K | -14.42K | -317.39K | -63.60K |
| Financing Cash Flow | 705.03M | 723.85M | 5.22M | 802.49K | 550.00K | -45.34K |
Nakamoto Inc Technical Analysis
Positive
4.87
Price Trends
4.45
Positive
6.00
Positive
11.15
Negative
Market Momentum
0.22
Negative
70.41
Negative
65.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NAKA, the sentiment is Positive. The current price of 4.87 is below the 20-day moving average (MA) of 4.94, above the 50-day MA of 4.45, and below the 200-day MA of 11.15, indicating a neutral trend. The MACD of 0.22 indicates Negative momentum. The RSI at 70.41 is Negative, neither overbought nor oversold. The STOCH value of 65.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NAKA.
Nakamoto Inc Risk Analysis
Nakamoto Inc disclosed 135 risk factors in its most recent earnings report. Nakamoto Inc reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Nakamoto Inc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | $855.70M | -11.91 | -26.30% | ― | 52.54% | 2.69% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | $1.39B | -11.43 | 1893.60% | ― | -100.00% | 19.23% | |
53 Neutral | $2.35B | -16.14 | -29.02% | ― | ― | -23.53% | |
50 Neutral | $89.65M | -0.17 | -105.45% | ― | 1658.09% | -3.49% | |
48 Neutral | $471.58M | -1.68 | -135.81% | ― | -94.63% | -39.78% |
* General Sector Average
NAKA
Nakamoto Inc
6.06
-397.54
-98.50%
EYPT
EyePoint Pharmaceuticals
6.30
-5.21
-45.26%
INBX
Inhibrx Biosciences Inc
101.48
77.07
315.73%
RAPP
Rapport Therapeutics, Inc.
49.07
34.75
242.67%
BBNX
Beta Bionics, Inc.
20.01
4.71
30.78%
Nakamoto Inc Corporate Events
Business Operations and StrategyExecutive/Board Changes
Nakamoto Inc Announces Executive Leadership Transition and Separation
Neutral
Aug 4, 2026
On August 3, 2026, Nakamoto Inc. announced that Tim Pickett resigned from all his roles with the company and its affiliates, including director, Chief Medical Officer, and Chief Executive Officer of Kindly LLC, with the company stating his departu...
Business Operations and StrategyStock BuybackDelistings and Listing ChangesPrivate Placements and FinancingRegulatory Filings and Compliance
Kindly MD Announces New Loan Terms and Buyback Plan
Positive
Jun 11, 2026
On June 5, 2026, Nakamoto Inc., through its subsidiary, restructured its borrowing under a Master Loan Agreement with Kraken by replacing an earlier loan with a 210,000,000 USDT facility secured by Bitcoin, then selling roughly 600 Bitcoin and rel...
Executive/Board ChangesDelistings and Listing ChangesRegulatory Filings and ComplianceShareholder MeetingsStock Split
Kindly MD Implements Reverse Stock Split and Governance Updates
Neutral
May 22, 2026
On May 21, 2026, Nakamoto Inc.’s board expanded from six to seven members and appointed Chief Investment Officer Tyler Evans as a Class II director through the 2026 annual meeting, without additional board compensation or committee roles. Th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.